HEMOPHILIA TREATMENT MARKET ANALYSIS
Global Hemophilia Treatment Market: Restraint
Increasing number of product recalls by regulatory authorities
Regulatory authorities are recalling products due to mislabelling on the cartons. For instance, in November 2020, mislabeling on cartons of four lots of Tranexamic Acid Injection, USP 1000 mg/10 mL were packed in cartons of 10 single-dose 10 mL vials. Thus, U.S. Food and Drug Administration recalled Tranexamic acid injection manufactured by Mylan, a generic and speciality pharmaceutical company. Hence, increasing number of product recalls is likely to hinder the market growth.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
